Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study

  • STATUS
    Not Recruiting
  • End date
    Jun 29, 2029
  • participants needed
    300
  • sponsor
    Sanofi
Send
Updated on 23 May 2025
See if I qualify

Summary

This study is a prospective, multinational, observational investigation designed to elucidate the real-world effectiveness and treatment patterns of dupilumab therapy in adult patients diagnosed with prurigo nodularis (PN).

The primary objective of this study is to comprehensively characterize the real-world usage of dupilumab for the management of PN.

In addition to this, the study aims to achieve several secondary objectives, including a detailed assessment of the medical history, socio-demographic and disease characteristics of dupilumab-treated PN patients, as well as the evaluation of the long-term real-world effectiveness of dupilumab therapy for PN.

Description

The follow-up period will be 36 months or until death, loss to follow-up, or withdrawal, whichever comes first.

Details
Condition Prurigo Nodularis
Age 18years or above
Clinical Study IdentifierNCT05991323
SponsorSanofi
Last Modified on23 May 2025

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.